Hydrochloric Acid

Hydrochloric Acid

SCHEMBL18547503

N#C[C@H]1CCNC1.[Cl-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL325385 0.95
SCHEMBL2223474 0.95
SCHEMBL1937488 0.95
Hydrochloric Acid SCHEMBL222471 0.92
Hydrochloric Acid SCHEMBL222662 0.92
Hydrochloric Acid SCHEMBL222472 0.92
SCHEMBL12259738 0.80
SCHEMBL1019673 0.80
SCHEMBL13632296 0.80
Hydrochloric Acid SCHEMBL21570235 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136326-B2 Pyrrolopyrimidine derivatives as TAM inhibitors INCYTE CORPORATION (US) 2021-10-05 US disclosed
US-20200181151-A1 PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS INCYTE CORPORATION 2020-06-11 US disclosed
US-20190031663-A1 PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS INCYTE CORPORATION 2019-01-31 US disclosed
US-10053465-B2 Pyrrolopyrimidine derivatives as TAM inhibitors INCYTE CORPORATION (US) 2018-08-21 US disclosed
US-20170057965-A1 PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS INCYTE CORPORATION 2017-03-02 US disclosed